Mediwound to participate in two upcoming investor conferences

Yavne, israel, feb. 05, 2024 (globe newswire) -- mediwound ltd. (nasdaq: mdwd), a fully integrated biopharmaceutical company focused on next-generation enzymatic therapeutics for tissue repair, today announced its participation in the upcoming oppenheimer 34th annual life sciences conference, taking place virtually on february 13-14, 2024, as well as the upcoming td cowen 44th annual health care conference, taking place in boston on march 4-6, 2024.
MDWD Ratings Summary
MDWD Quant Ranking